Aprile Pilon

Chief Executive Officer at Trove Therapeutics, Inc.

Aprile Pilon is the Founder and Acting Chief Executive Officer of Trove Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on developing innovative treatments for respiratory diseases. Based in Rockville, Maryland, she has been in this role since November 2018. Under her leadership, Trove Therapeutics is working on a first-in-class biologic drug known as Therabron, derived from the human CC10 protein, which has shown promise in treating conditions like acute respiratory distress syndrome (ARDS) and other lung injuries.1 2

Background and Education

Dr. Pilon holds a Bachelor of Arts in Physics from Wheaton College and a Ph.D. in Molecular and Cell Biology from Pennsylvania State University, where she completed her doctorate in 1989. Following her education, she trained as a post-doctoral fellow at the National Institutes of Health before embarking on a career in the biotech industry.2 3

Professional Experience

Founder & CEO, Trove Therapeutics, Inc. (2018 - Present): Leading the development of novel therapies aimed at improving respiratory health outcomes.
Founder, APCBio Innovations, Inc. (2017 - Present): A contract research organization supporting Trove's research initiatives.
Previous Roles: She has held various leadership positions in other biotech companies, including Therabron Therapeutics and APC Biotechnology Services, showcasing her extensive experience in the biopharmaceutical sector.1 2 4

Contributions and Impact

Dr. Pilon is recognized for her entrepreneurial spirit and scientific expertise, holding over 30 patents related to secretoglobin-based therapeutics. Her work aims to revolutionize the management of critical care patients and those suffering from chronic respiratory conditions.2 5